Trade ACET stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Adicet Bio, Inc. (ACET) is trading at US$6.47, down 0.46% today as of Oct 5, 16:00 EDT. The company has a market capitalisation of US$86.03M. Over the past 52 weeks, ACET has traded between US$6.01 and US$17.44. On Syfe you can trade ACET with $0 commission and add it to your watchlist.
| Previous close | US$6.50 |
|---|---|
| Market cap | US$86.03M |
| 52-week range | US$6.01 – US$17.44 |
| Volume | 152.15K |
| Exchange | US |
Adicet Bio, Inc.
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Year: 2020
Adicet Bio Gets FDA Clearance for IND for ADI-212 in prostate cancer
Aug 27, 9:00 PM · MT Newswires
Adicet Bio, Inc. (ACET) stock is trading at US$6.47, -0.46% from the previous close of US$6.50.
The market cap for Adicet Bio, Inc. (ACET) stock is approximately US$86.03M.
The 52-week high for Adicet Bio, Inc. (ACET) stock is US$17.44.
The 52-week low for Adicet Bio, Inc. (ACET) stock is US$6.01.
Adicet Bio, Inc. (ACET) does not currently pay a dividend.
Stay on top of ACET
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
